We investigated the mechanisms of alphafetoprotein (AFP) transfer across the human placenta by correlating measurements of AFP transfer with cytochemical localization of AFP. Placental cotyledons were dually perfused in vitro with either the fetal or maternal perfusate containing umbilical cord plasma as a source of AFP. Steady state AFP clearance, corrected for release of endogenous AFP, was 0.973±0.292 ,ul/min per gram in the fetal to maternal direction (n = 10), signfficantly higher (P < 0.02) than that in the maternal to fetal direction (n = 5; 0.022+0.013 ,ul/min per gram). Clearance of a similarly sized protein, horseradish peroxidase was also asymmetric but clearance of the small tracer creatinine was not. Using a monoclonal antibody, we localized AFP to fibrinoid deposits in regions of villi with discontinuities of the syncytiotrophoblast, to cytotrophoblast cells in these deposits, to syncytiotrophoblast on some villi, and to trophoblast cells in the decidua. We conclude that AFP transfer in the placenta is asymmetric and that there are two available pathways for AFP transfer: (a) from the fetal circulation into the villous core and across fibrinoid deposits at discontinuities in the villous syncytiotrophoblast to enter the maternal circulation; and (b) AFP present in the decidua could enter vessels that traverse the basal plate. (J. Clin. Invest. 1995Invest. . 96:2220Invest. -2226
Introduction
Measurement of the maternal serum alphafetoprotein (MSAFP)' concentration in the second trimester is a common 1 . Abbreviations used in this paper. AFP, alphafetoprotein; HRP, horseradish peroxidase; MSAFP, maternal serum AFP; K, unidirectional clearance. component of pregnancy care. Elevated MSAFP levels were originally used to screen for fetal neural tube defects. However, recent data indicate that in the absence of fetal anomalies a high MSAFP concentration in the mid-trimester is associated with intrauterine growth retardation, preeclampsia, and increased perinatal mortality ( 1) . Increased fetal to maternal transfer of alphafetoprotein (AFP) across the placenta due to increased placental permeability is often implicated as an etiology for the higher MSAFP level where there is no fetal anomaly. However, this assumption has not been tested directly since the mechanisms involved in AFP transfer in normal pregnancy are unknown.
There are four anatomical barriers for proteins passing between the maternal and fetal circulations of the human placenta: the syncytiotrophoblast which is bathed by maternal blood in the intervillous space, the trophoblastic and capillary basement membranes, and the fetal capillary endothelium. Gitlin (2) suggested that placental transfer of APP is by diffusion. Both in vivo and in vitro studies have shown that the permeability of the human placenta to inert, hydrophilic tracers is proportional to their coefficients of free diffusion in water (3) (4) (5) (6) (7) (8) (9) showing that transfer by paracellular diffusion can occur for a molecule such as AFP. The anatomical correlate for the paracellular route of diffusion in the human placental villus is controversial since the syncytiotrophoblast is a true syncytium. However, we reported that discontinuities in the syncytiotrophoblast layer were present on placental villi from uncomplicated pregnancies and were associated with fibrin containing fibrinoid deposits (10). This observation allowed us to identify these discontinuities as one paracellular route for diffusion of hydrophilic molecules from the maternal to fetal circulation.
The aim of the present study was to investigate the mechanisms of AFP transfer across placental villi from uncomplicated pregnancies. We correlated quantitative measurements of AFP transfer between the fetal and maternal circulations in the dually perfused human placental cotyledon with cytochemical localization of AFP immunoreactivity in sections of perfused tissue. This also allowed us to test the hypothesis that areas of syncytial discontinuity on the villous surface provide one route for AFP transfer between the fetal and maternal circulations.
As the data suggested that AFP clearance in the fetal to maternal direction is greater than that in the maternal to fetal direction, we also measured the fetal to maternal clearance of the similarly sized (molecular radius 3-4 nm) protein horseradish peroxidase (HRP). This allowed comparison to our previous data on maternal to fetal HRP clearance (9) and determination of whether the asymmetry in clearances was a phenomenon affecting all macromolecules.
Methods
This study was approved by the Central Manchester Health Authority Ethical Committee.
The placentas from uncomplicated term pregnancies were obtained after vaginal delivery (n = 16) or cesarean section (n = 9) from women whose MSAFP concentrations were less than two multiples of the median when measured during the second trimester. Cotyledons (42.4±4.3 grams; mean±SEM) were perfused by the method of Schneider, Panigel, and Dancis ( 11) as adapted in our laboratory (9) . The (12) . This RIA uses a well characterized antibody which is unreactive with other serum proteins; the assay has a sensitivity of 5 ng/ml and a coefficient of variation of < 10% at the analyte ranges used. Because blood is incompletely removed from the fetal circulation of perfused cotyledons (13) , there was release of AFP endogenous to the tissue. We measured this endogenous AFP output into the fetal and maternal perfusates in the three preparations dually perfused with the Earle's salt solution without added cord plasma. These data were used to correct for release of endogenous AFP in experiments where AFP was added to one of the perfusates, as detailed further in Results.
HRP was assayed as previously described (9, 14) . During the course of this study we found that effluent perfusate contained endogenous peroxidase activity, most likely due to hemoglobin in the samples. However, in the absence of added HRP, the absorbance of perfusate samples at 414 nm (a wavelength at which HRP at the concentrations used here does not absorb) was linearly correlated (r2 = 0.99) with the endogenous peroxidase activity. Therefore, in experiments with added HRP, measurement of absorbance of perfusate effluent samples at 414 nm, together with the standard curve (endogenous peroxidase activity versus absorbance at 414 nm), allowed us to correct data for endogenous peroxidase activity. In our previous study of maternal to fetal transfer of HRP (9) we had not been aware of the endogenous peroxidase activity so the clearances reported are therefore an overestimate of the true maternal to fetal HRP clearance. However, we had stored frozen all the samples from that study so that we were able to reanalyze them and correct for the endogenous peroxidase activity. Staining sections of a human yolk sac germ cell tumor known to express AFP immunoreactivity provided a positive control. Duplicate sets of placental sections from each experiment were compared to these positive and negative control slides by an observer blinded to the treatment conditions. The presence or absence of AFP immunoreactivity was systematically evaluated in the syncytiotrophoblast, the endothelium and connective tissue of the villous core, the fibrin containing fibrinoid deposits, and the decidua, when the plane of section happened to include this area of the cotyledon.
Results
General. 17 of 27 preparations used in clearance experiments which fulfilled our perfusate recovery criteria also fulfilled our morphological criteria. 5 of the 17 were used to study maternal to fetal AFP clearances and one was used to measure maternal to fetal HRP clearance. Of the remaining 11, 10 were used to study fetal to maternal AFP clearances, six of which were also Alphafetoprotein Transfer in the Human Placenta 2221 150 -* * * AFP, HRP, and creatinine clearances. Blood present in the perfused cotyledons is incompletely removed (14) , and thus, we noted a continuous elution of AFP into the perfusates throughout the perfusion time period studied when cord plasma was not added to the perfusion medium. This release of endogenous AFP is shown in Fig. 1 , where AFP concentrations in perfusate samples are illustrated as a percentage of the AFP concentration in the perfusate measured at time zero (i.e., 15-20 min after establishing dual perfusion of the fetal vasculature and maternal intervillous space). Endogenous AFP release into the fetal circulation was relatively constant over the time course of the experiments whereas endogenous AFP release from the maternal circulation slowly decreased. In each experiment where AFP was to be added to either the maternal or fetal perfusate, we measured the AFP concentration in the time zero sample obtained before perfusion with the medium containing cord plasma. This AFP concentration in the time zero perfusate and the data shown in Fig. 1 was used to estimate the contribution of endogenous AFP to total AFP measured in each acceptor circulation sample subsequently collected.
Clearance data for AFP are illustrated without correction for endogenous AFP release in Fig. 2 a and with correction for endogenous AFP release in Fig. 2 Cotyledons were initially perfused with Earle's bicarbonate buffer containing 5.6 mM glucose, 0.5 mM dextran 70, and 0.017 mM BSA. After 15-20 min of dual perfusion Earle's bicarbonate buffer containing 5.6 mM glucose, 4.4 mM creatinine, and either 20 or 50% (vol/vol) umbilical cord plasma was perfused through the maternal circulation (in experiments where maternal to fetal clearance was measured; *) or through the fetal circulation (in experiments where fetal to maternal clearance was measured; ,) while the standard perfusate without cord plasma was maintained through the opposite circulation. AFP was measured in timed samples using an RIA and clearance calculated. Mean±SEM; n = 5 for maternal-fetal clearance and n = 10 for fetal-maternal clearance; * P < 0.02 vs maternal-fetal clearance (Mann Whitney U test).
per gram placenta when corrected for endogenous AFP. In contrast, maternal to fetal AFP clearance showed minimal change over the time course studied. When corrected for endogenous AFP, maternal to fetal AFP clearance (K = 0.022±0.013 ,ul/ min per gram placenta) was not significantly different from zero (Fig. 2 b) . Fetal to maternal AFP clearance was significantly (P < 0.02, Mann-Whitney U test) higher than maternal to fetal AFP clearance at steady state (40 min) whether or not the correction for endogenous AFP was made (Fig. 2) .
Fetal to maternal HRP clearance, corrected for endogenous peroxidase activity, was very similar to that for AFP in this direction and, at steady state (40 min) was 0.783±0.232 ,u/ min per gram placenta (n = 7). For comparison we reanalyzed samples from our previous study of maternal to (Fig. 4 A) . The expected pa was present in nests of cell yolk sac germ tumor knowr qualitative localization of ir in placental tissues perfused cord plasma as a source of j with the AFP containing ca brown staining in the matr taining deposits and the basa tivity was present in cytotri brinoid deposits (Fig. 4 C) E) identified when the basz happened to be included in tl reactivity was additionally 1 of some, but not all, of the f the syncytiotrophoblast of sc 4 C and G). The villous cor tissue cells, the trophoblast and capillary basement membranes, and the fetal vessel endothelium showed no specific immunoreactivity for AFP (Fig. 4 F) iotrophoblast; the AFP present in the decidua basalis can access e was measured; A) while the standard the maternal circulation by entering the vessels that traverse the {as maintained through the opposite basal plate. ured using a calorimetric assay and
The clearance across the placenta due to paracellular diffu-M; n = 5 for maternal-fetal clearance sion of an inert, hydrophilic, nonelectrolyte solute that is not learance.
limited by flow should be symmetrical (15) . Creatinine is a tracer with the listed characteristics and creatinine clearance in this study was symmetrical. In contrast, the clearance of AFP ificantly (P < 0.05; Mann Whitney was asymmetrical and predominantly unidirectional from fetal CP in the fetal to maternal direction.
to maternal circulations. The need to correct the clearance data e significantly (paired t test) over for the endogenous AFP release may mask a small amount of ntal perfusion and then reached a AFP transfer from maternal to fetal circulations and yet, whatntrast to AFP and HRP, there was ever the error in actual values, AFP clearance remains signifir the maternal to fetal creatinine cantly higher for transfer from the fetal to maternal circulation, min per gram placenta) compared compared to the transfer from the maternal to fetal compartinine clearance (K = 24.9±6.1 piL/ ment. The asymmetrical clearance of AFP suggests that a more le used a monoclonal antibody and complex mechanism exists for transfer of this protein than paralocalize AFP immunoreactivity in cellular diffusion. The most likely explanation for the asymmem the perfused cotyledons. No imtry is that the fetal to maternal clearance of AFP was higher d in negative control sections of than predicted by a paracellular diffusion model because there nouse ascites fluid, rich in proteins, was bulk flow of perfusate containing AFP from the fetal to the substituted for the AFP antibody maternal circulation. The data showing that the clearance of ttern of immunoreactivity for AFP HRP, a protein not normally handled by the placenta, is also s in positive control sections of a asymmetric is consistent with this bulk flow hypothesis. A fetal n to express AFP (Fig. 4 B) . The to maternal hydrostatic pressure gradient would drive such bulk nmunoreactive AFP was identical flow across the placental villous exchange area. Schneider and with or without medium containing colleagues (17) have previously demonstrated this in experi-AFP, although specimens perfused ments where, using the perfused human placental cotyledon, ord serum did tend to have more increases in fetal venous pressure were shown to significantly rix components of the fibrin-conincrease fetal to maternal clearance of a 70,000 MW dextran, 1 plate. Specific AFP immunoreacbut not that of their small extracellular tracer, L-glucose. Alophoblast cells associated with fithough direct measurement of hydrostatic pressures at the level and in the decidua (Fig. 4, D and of exchange was not possible, the fetal arterial perfusion presal plate of the perfused cotyledon sures were higher than those in the maternal intervillous space ie tissue section. The AFP immunoin our experiments. We calculate that only 0.054 ml/min of ocalized to noncellular components perfusate would need to be filtered from the fetal to maternal fibrinoid deposits (Fig. 4 F) docytosis of the AFP molecule, as described for other fetal cells Fibrin containing fibrinoid deposits occur at discontinuities (22) . Understanding whether the trophoblast either produces in the syncytiotrophoblast as a common histologic feature of or endocytoses AFP is of particular interest in light of recent villi from term human placentas (10, 20) . The AFP immunoredata associating low maternal serum AFP levels with pregnanactivity identified cytochemically in some, but not all, of the cies complicated with trisomic fetuses (23) . The mere presence deposits in sections of perfused tissue indicate that one available of AFP in the basal plate provides a source for maternal serum route for paracellular transfer of AFP between the fetal and AFP elevations associated with placenta accreta (24), a pathomaternal circulations is through the syncytiotrophoblast layer logical pregnancy condition associated with abnormal basal at the discontinuities in the syncytium. The AFP immunoreacplate anatomy. tivity of cytotrophoblast in these deposits suggests that AFP
The assumption that AFP passes from the fetal to maternal uptake, if not synthesis, occurs in these cells and such uptake compartments via the amnion or the placenta is implicit in might modify measured AFP clearance to a small degree. Many correlating AFP levels with clinical conditions in normal and deposits did not exhibit immunoreactivity for AFP and no imabnormal pregnancies (1). The mechanism for elevated matermunoreactivity for AFP was identified in capillary endothelium, nal serum AFP concentrations when abnormal fetal anatomy is villous core connective tissue, or the basement membranes of present is well described, as this serum protein passes from the trophoblast or capillaries. This contrasts with our study of mafetal circulation across surfaces without skin to enter amniotic ternal to fetal clearance of horseradish peroxidase, a protein of fluid and ultimately the maternal circulation. However, the spesimilar molecular weight to AFP, in the perfused cotyledon cific mechanisms for AFP transfer in pregnancies without anommodel. Cytochemical localization of peroxidase in sections of alies have not been delineated. In such pregnancies elevated perfused tissues included not only the fibrinoid deposits but also mid-trimester AFP concentrations have been associated with the trophoblastic basement membrane and villous core macroincreased placental volume, abnormal basal plate anatomy, phages (9) . We are therefore uncertain how AFP exiting the chronic villitis, and placental infarction at term (24) (25) (26) . Our fetal circulation gains access to the fibrinoid deposits on the evaluation of AFP transfer in perfused human placental cotylevillous surface. The ability to detect AFP cytochemically is dons from uncomplicated pregnancy not only indicates that the limited by the number of AFP molecules per unit area of tissue AFP can cross the placental villus, but also offers microscopic section and the affinity of the monoclonal antibody for its AFP mechanisms to explain why enhanced AFP transfer occurs in antigen, among other factors. Fibrinoid contains fibrin and many the presence of gross abnormalities of the placenta. We suggest other serum proteins to which AFP molecules, perhaps nonspethat the elevated MSAFP levels in some high risk pregnancies may reflect increased damage to the syncytiotrophoblast of placental villi or abnormal disruption of vessels passing through the basal plate. An increased number of discontinuities in the syncytiotrophoblast would provide more surface area for fetal to maternal AFP passage by either diffusion or filtration, and ultimately higher maternal serum AFP concentration. The AFP molecules in the decidua would have increased access to the maternal circulation if the basal plate anatomy were disrupted, especially if vessels passing through the area were involved. The extent to which irreparable damage to trophoblast or basal plate occurs would determine which pregnancies with elevated mid-trimester AFP levels result in poor pregnancy outcome, including perinatal loss, preeclampsia, or intrauterine growth abnormalities. The capacity of the human placenta to repair itself would explain why most pregnancies with elevated midtrimester AFP concentrations proceed to normal outcomes. In summary our data show, firstly, that there is asymmetric clearance of AFP across the perfused human placental cotyledon; such asymmetric transfer would be exaggerated in vivo by the considerably higher concentration of AFP in fetal as compared to maternal plasma (2) . Secondly, one available route of AFP transfer across the syncytiotrophoblast is across areas of syncytial discontinuity in the villous surface. Finally our data suggest that trophoblasts can alter AFP production and metabolism either by synthesizing or endocytozing this protein.
